Multiple hyperlinks to rcsb

Your request to link to rcsb for Proto-oncogene tyrosine-protein kinase Src

1F1W: src sh2 thref1trp mutant complexed with the phosphopeptide s(ptr)vnvqn (10.1016/S1097-2765(00)80269-5 )
1F2F: src sh2 thref1trp mutant (10.1016/S1097-2765(00)80269-5 )
1FMK: crystal structure of human tyrosine-protein kinase c-src (10.1038/385595A0 )
1HCS: nmr structure of the human src sh2 domain complex (10.1021/BI00007A003 )
1HCT: nmr structure of the human src sh2 domain complex (10.1021/BI00007A003 )
1IS0: crystal structure of a complex of the src sh2 domain with conformationally constrained peptide inhibitor (10.1021/JA011746F )
1KC2: structure of the triple (lys(beta)d3ala, asp(beta)c8ala, aspcd2ala) mutant of the src sh2 domain bound to the pqpyeeipi peptide (10.1006/JMBI.2001.5362 )
1KSW: structure of human c-src tyrosine kinase (thr338gly mutant) in complex with n6-benzyl adp (10.1016/S1074-5521(02)00091-1 )
1NLO: structure of signal transduction protein, nmr, minimized average structure (10.1016/S1074-5521(96)90134-9 )
1NLP: structure of signal transduction protein, nmr, minimized average structure (10.1016/S1074-5521(96)90134-9 )
1NZL: crystal structure of src sh2 domain bound to doubly phosphorylated peptide pqpyepyipi (10.1016/S0022-2836(03)00344-9 )
1NZV: crystal structure of src sh2 domain bound to doubly phosphorylated peptide pqpyipyvpa (10.1016/S0022-2836(03)00344-9 )
1O41: crystal structure of sh2 in complex with ru78300. (10.1021/JM020970S )
1O42: crystal structure of sh2 in complex with ru81843. (10.1021/JM020970S )
1O43: crystal structure of sh2 in complex with ru82129. (10.1021/JM020970S )
1O44: crystal structure of sh2 in complex with ru85052 (10.1021/JM020970S )
1O45: crystal structure of sh2 in complex with ru84687. (10.1021/JM020970S )
1O46: crystal structure of sh2 in complex with ru90395. (10.1021/JM020970S )
1O47: crystal structure of sh2 in complex with ru82209. (10.1021/JM020970S )
1O48: crystal structure of sh2 in complex with ru85053. (10.1021/JM020970S )
1O49: crystal structure of sh2 in complex with ru85493. (10.1021/JM020970S )
1O4A: crystal structure of sh2 in complex with ru82197. (10.1021/JM020970S )
1O4B: crystal structure of sh2 in complex with ru83876. (10.1021/JM020970S )
1O4C: crystal structure of sh2 in complex with phosphate. (10.1021/JM020970S )
1O4D: crystal structure of sh2 in complex with ru78262. (10.1021/JM020970S )
1O4E: crystal structure of sh2 in complex with ru78299. (10.1021/JM020970S )
1O4F: crystal structure of sh2 in complex with ru79073. (10.1021/JM020970S )
1O4G: crystal structure of sh2 in complex with dpi59. (10.1021/JM020970S )
1O4H: crystal structure of sh2 in complex with ru79072. (10.1021/JM020970S )
1O4I: crystal structure of sh2 in complex with pas219. (10.1021/JM020970S )
1O4J: crystal structure of sh2 in complex with iso24. (10.1021/JM020970S )
1O4K: crystal structure of sh2 in complex with pasbn. (10.1021/JM020970S )
1O4L: crystal structure of sh2 in complex with fragment2. (10.1021/JM020970S )
1O4M: crystal structure of sh2 in complex with malonicacid. (10.1021/JM020970S )
1O4N: crystal structure of sh2 in complex with oxalic acid. (10.1021/JM020970S )
1O4O: crystal structure of sh2 in complex with phenylphosphate. (10.1021/JM020970S )
1O4P: crystal structure of sh2 in complex with ru78791. (10.1021/JM020970S )
1O4Q: crystal structure of sh2 in complex with ru79256. (10.1021/JM020970S )
1O4R: crystal structure of sh2 in complex with ru78783. (10.1021/JM020970S )
1P13: crystal structure of the src sh2 domain complexed with peptide (sdpyanfk) (10.1021/BI0340503 )
1PRL: two binding orientations for peptides to src sh3 domain: development of a general model for sh3-ligand interactions
1PRM: two binding orientations for peptides to src sh3 domain: development of a general model for sh3-ligand interactions
1QWE: c-src sh3 domain complexed with ligand app12 (10.1073/PNAS.92.26.12408 )
1QWF: c-src sh3 domain complexed with ligand vsl12 (10.1073/PNAS.92.26.12408 )
1RLP: two binding orientations for peptides to src sh3 domain: development of a general model for sh3-ligand interactions
1RLQ: two binding orientations for peptides to src sh3 domain: development of a general model for sh3-ligand interactions
1SHA: crystal structure of the phosphotyrosine recognition domain sh2 of v-src complexed with tyrosine-phosphorylated peptides (10.1038/358646A0 )
1SHB: crystal structure of the phosphotyrosine recognition domain sh2 of v-src complexed with tyrosine-phosphorylated peptides (10.1038/358646A0 )
1SHD: peptide inhibitors of src sh3-sh2-phosphoprotein interactions
1SKJ: cocrystal structure of urea-substituted phosphopeptide complex (10.1021/JM970402Q )
1SPR: binding of a high affinity phosphotyrosyl peptide to the src sh2 domain: crystal structures of the complexed and peptide-free forms (10.1016/0092-8674(93)90405-F )
1SPS: binding of a high affinity phosphotyrosyl peptide to the src sh2 domain: crystal structures of the complexed and peptide-free forms (10.1016/0092-8674(93)90405-F )
1SRL: 1h and 15n assignments and secondary structure of the src sh3 domain (10.1016/0014-5793(93)81538-B )
1SRM: 1h and 15n assignments and secondary structure of the src sh3 domain (10.1016/0014-5793(93)81538-B )
1Y57: structure of unphosphorylated c-src in complex with an inhibitor (10.1016/J.STR.2005.03.012 )
1YI6: c-term tail segment of human tyrosine kinase (258-533)
1YOJ: crystal structure of src kinase domain (10.1016/J.JMB.2005.08.023 )
1YOL: crystal structure of src kinase domain in complex with cgp77675 (10.1016/J.JMB.2005.08.023 )
1YOM: crystal structure of src kinase domain in complex with purvalanol a (10.1016/J.JMB.2005.08.023 )
2BDF: src kinase in complex with inhibitor ap23451 (10.1111/J.1747-0285.2005.00316.X )
2BDJ: src kinase in complex with inhibitor ap23464 (10.1111/J.1747-0285.2005.00316.X )
2H8H: src kinase in complex with a quinazoline inhibitor (10.1021/JM060434Q )
2HWO: crystal structure of src kinase domain in complex with covalent inhibitor (10.1038/NCHEMBIO866 )
2HWP: crystal structure of src kinase domain in complex with covalent inhibitor pd168393 (10.1038/NCHEMBIO866 )
2JYQ: nmr structure of the apo v-src sh2 domain (10.1002/PROT.22119 )
2OIQ: crystal structure of chicken c-src kinase domain in complex with the cancer drug imatinib. (10.1016/J.STR.2007.01.015 )
2PTK: chicken src tyrosine kinase (10.1006/JMBI.1997.1426 )
2QI8: crystal structure of drug resistant src kinase domain (10.1016/J.BMC.2008.02.053 )
2QLQ: crystal structure of src kinase domain with covalent inhibitor rl3 03-mar-09 2qlq 1 versn title (10.1016/J.BMC.2008.02.053 )
2QQ7: crystal structure of drug resistant src kinase domain with irreversible inhibitor (10.1016/J.BMC.2008.02.053 )
2SRC: crystal structure of human tyrosine-protein kinase c-src, in complex with amp-pnp (10.1016/S1097-2765(00)80356-1 )
3D7T: structural basis for the recognition of c-src by its inactivator csk (10.1016/J.CELL.2008.05.051 )
3D7U: structural basis for the recognition of c-src by its inactivator csk (10.1016/J.CELL.2008.05.051 )
3DQW: c-src kinase domain thr338ile mutant in complex with atpgs (10.1038/NSMB.1486 )
3DQX: chicken c-src kinase domain in complex with atpgs (10.1038/NSMB.1486 )
3EL7: crystal structure of c-src in complex with pyrazolopyrimidine 3 (10.1016/J.CHEMBIOL.2008.09.007 )
3EL8: crystal structure of c-src in complex with pyrazolopyrimidine 5 (10.1016/J.CHEMBIOL.2008.09.007 )
3EN4: targeted polypharmacology: crystal structure of the c-src kinase domain in complex with pp121, a multitargeted kinase inhibitor (10.1038/NCHEMBIO.117 )
3EN5: targeted polypharmacology: crystal structure of the c-src kinase domain in complex with pp494, a multitargeted kinase inhibitor (10.1038/NCHEMBIO.117 )
3EN6: targeted polypharmacology: crystal structure of the c-src kinase domain in complex with pp102, a multitargeted kinase inhibitor (10.1038/NCHEMBIO.117 )
3EN7: targeted polypharmacology: crystal structure of the c-src kinase domain in complex with s1, a multitargeted kinase inhibitor (10.1038/NCHEMBIO.117 )
3F3T: kinase domain of csrc in complex with inhibitor rl38 (type iii) (10.1038/NCHEMBIO.162 )
3F3U: kinase domain of csrc in complex with inhibitor rl37 (type iii) (10.1038/NCHEMBIO.162 )
3F3V: kinase domain of csrc in complex with inhibitor rl45 (type ii) (10.1021/JM9002928 )
3F3W: drug resistant csrc kinase domain in complex with inhibitor rl45 (type ii) (10.1021/JM9002928 )
3F6X: c-src kinase domain in complex with small molecule inhibitor (10.1021/JA807066F )
3FJ5: crystal structure of the c-src-sh3 domain (10.1016/J.FEBSLET.2009.01.036 )
3G5D: kinase domain of csrc in complex with dasatinib (10.1021/JM9002928 )
3G6G: equally potent inhibition of c-src and abl by compounds that recognize inactive kinase conformations (10.1158/0008-5472.CAN-08-3953 )
3G6H: src thr338ile inhibited in the dfg-asp-out conformation (10.1158/0008-5472.CAN-08-3953 )
3GEQ: structural basis for the chemical rescue of src kinase activity (10.1021/BI900057G )
3LOK: drug resistant csrc kinase domain in complex with covalent inhibitor pd168393 (10.1002/CBIC.201000352 )
3OEZ: crystal structure of the l317i mutant of the chicken c-src tyrosine kinase domain complexed with imatinib
3OF0: crystal structure of the l317i mutant of the chicken c-src tyrosine kinase domain
3QLF: crystal structure of the l317i mutant of the c-src tyrosine kinase domain complexed with pyrazolopyrimidine 5
3QLG: crystal structure of the l317i mutant of the c-src tyrosine kinase domain complexed with dasatinib
3SVV: crystal structure of t338c c-src covalently bound to vinylsulfonamide- pyrazolopyrimidine 9 (10.1073/PNAS.1111239108 )
3TZ7: kinase domain of csrc in complex with rl103
3TZ8: kinase domain of csrc in complex with rl104
3TZ9: kinase domain of csrc in complex with rl130
3U4W: src in complex with dna-templated macrocyclic inhibitor mc4b (10.1038/NCHEMBIO.792 )
3U51: src in complex with dna-templated macrocyclic inhibitor mc1 (10.1038/NCHEMBIO.792 )
3UQF: c-src kinase domain in complex with bki rm-1-89 (10.1021/JM201725V )
3UQG: c-src kinase domain in complex with bumpless bki analog uw1243 (10.1021/JM201725V )
4AGW: discovery of a small molecule type ii inhibitor of wild-type and gatekeeper mutants of bcr-abl, pdgfralpha, kit, and src kinases (10.1182/BLOOD-2009-11-251751 )
4DGG: c-src kinase domain in complex with rm-1-176 (10.1038/NCHEMBIO.1118 )
4F59: triple mutant src sh2 domain (10.1126/SCISIGNAL.2003021 )
4F5A: triple mutant src sh2 domain bound to phosphate ion (10.1126/SCISIGNAL.2003021 )
4F5B: triple mutant src sh2 domain bound to phosphotyrosine (10.1126/SCISIGNAL.2003021 )
4FIC: kinase domain of csrc in complex with a hinge region-binding fragment (10.1021/CB300729Y )
4HVU: crystal structure of the t98d c-src-sh3 domain mutant in complex with the high affinity peptide app12 (10.1107/S0907444913001522 )
4HVV: crystal structure of the t98e c-src-sh3 domain mutant in complex with the high affinity peptide app12 (10.1107/S0907444913001522 )
4HVW: crystal structure of the t98e c-src-sh3 domain mutant in complex with the high affinity peptide vsl12 (10.1107/S0907444913001522 )
4HXJ: crystal structure of sh3:rgt complex (10.1182/BLOOD-2012-07-440644 )
4JZ3: crystal structure of the chicken c-src-sh3 domain intertwined dimer (10.1371/JOURNAL.PONE.0113224 )
4JZ4: crystal structure of chicken c-src-sh3 domain: monomeric form (10.1371/JOURNAL.PONE.0113224 )
4K11: the structure of 1na in complex with src t338g
4LGG: structure of 3mb-pp1 bound to analog-sensitive src kinase (10.1021/CB400376P )
4LGH: crystal structure of 1nm-pp1 bound to analog-sensitive src kinase (10.1021/CB400376P )
4MCV: star 12 bound to analog-sensitive src kinase (10.1021/JA408704U )
4MXO: human src kinase bound to kinase inhibitor bosutinib (10.1038/NCHEMBIO.1404 )
4MXX: human src a403t mutant bound to kinase inhibitor bosutinib (10.1038/NCHEMBIO.1404 )
4MXY: src m314l t338m double mutant bound to kinase inhibitor bosutinib (10.1038/NCHEMBIO.1404 )
4MXZ: src m314l t338m double mutant bound to kinase inhibitor bosutinib (10.1038/NCHEMBIO.1404 )
4O2P: kinase domain of csrc in complex with a substituted pyrazolopyrimidine (10.1021/JM5013159 )
4OML: crystal structure of the intertwined dimer of the c-src tyrosine kinase sh3 domain mutant q128r (10.1371/JOURNAL.PONE.0113224 )
4OMM: crystal structure of the intertwined dimer of the c-src tyrosine kinase sh3 domain mutant n113s
4OMN: crystal structure of the intertwined dimer of the c-src tyrosine kinase sh3 domain mutant q128e (10.1371/JOURNAL.PONE.0113224 )
4OMO: crystal structure of the c-src tyrosine kinase sh3 domain mutant q128e (10.1371/JOURNAL.PONE.0113224 )
4OMP: crystal structure of the intertwined dimer of the c-src tyrosine kinase sh3 domain mutant q128k (10.1371/JOURNAL.PONE.0113224 )
4OMQ: crystal structure of the intertwined dimer of the c-src tyrosine kinase sh3 domain mutant s94a
4QT7: crystal structure of the c-src sh3 domain in complex with a peptide from the hepatitis c virus ns5a-protein (10.1016/J.JSB.2014.11.004 )
4RTU: crystal structure of the intertwined form of the src tyrosine kinase sh3 domain t96g/q128r mutant
4RTV: crystal structure of the src tyrosine kinase sh3 domain s94a/q128r mutant in complex with the high affinity synthetic peptide app12
4RTW: crystal structure of the c-src-sh3 domain e93v/q128r mutant in complex with the high affinity peptide app12
4RTX: crystal structure of the src tyrosine kinase sh3 domain t96g/q128r mutant
4RTY: crystal structure of the c-src-sh3 domain in complex with the high affinity peptide app12
4RTZ: crystal structure of the c-src-sh3 domain in complex with the high affinity peptide vsl12
4U5J: c-src in complex with ruxolitinib (10.1371/JOURNAL.PONE.0106225 )
4Y92: crystal structure of the intertwined form of the src tyrosine kinase sh3 domain e97t-q128r mutant
4YBJ: type ii dasatinib analog crystallized with c-src kinase (10.1021/ACSCHEMBIO.5B01018 )
4YBK: c-helix-out dasatinib analog crystallized with c-src kinase (10.1021/ACSCHEMBIO.5B01018 )
5BMM: src in complex with dna-templated macrocyclic inhibitor mc25b (10.1016/J.CHEMBIOL.2016.07.017 )
5D10: kinase domain of csrc in complex with rl236 (10.1021/ACS.JMEDCHEM.5B01082 )
5D11: kinase domain of csrc in complex with rl235 (10.1021/ACS.JMEDCHEM.5B01082 )
5D12: kinase domain of csrc in complex with rl40 (10.1021/ACS.JMEDCHEM.5B01082 )
5EC7: crystal structure of a chimeric c-src-sh3 domain with the sequence of the rt-loop from the abl-sh3 domain at ph 5.0
5ECA: crystal structure of a chimeric c-src-sh3 domain with the sequence of the rt-loop from the abl-sh3 domain at ph 6.5
5I11: crystal structure of the intertwined form of the src tyrosine kinase sh3 domain t114s-q128r mutant
5J5S: src kinase in complex with a sulfonamide inhibitor
5K9I: crystal structure of c-src in complex with a covalent lysine probe (10.1021/JACS.6B08536 )
5OAV: high resolution crystal structure of the c-src-sh3 domain mutant e93v in complex with the high affinity synthetic peptide app12: monoclinic crystal
5OB0: crystal structure of the c-src-sh3 domain q128e mutant in complex with the high affinity peptide app12
5OB1: crystal structure of the c-src-sh3 domain q128r mutant in complex with the high affinity peptide app12
5OB2: crystal structure of the c-src-sh3 domain e97t mutant in complex with the high affinity peptide app12
5SWH: c-src v281c kinase domain in complex with rao-iv-151
5SYS: c-src v281c bound to n-[3-({6-[(1e)-2-cyano-3-(methylamino)-3-oxoprop- 1-en-1-yl]-7-(2-methoxyethyl)-7h-pyrrolo[2,3-d]pyrimidin-5- yl}ethynyl)-4-methylphenyl]-3-(trifluoromethyl)benzamide inhibitor
5T0P: c-src kinase domain in complex with rao-iv-151
5TEH: c-src v281c kinase domain in complex with rao-iv-156
5XP5: c-src in complex with atp-chf (10.1021/JACS.7B03266 )
5XP7: c-src in complex with atp-chcl (10.1021/JACS.7B03266 )
6ATE: src kinase bound to covalent inhibitor (10.1016/J.CHEMBIOL.2019.02.021 )
6C4S: human csrc sh3 domain in complex with choline kinase fragment 60-69 (10.1038/S41598-019-53447-0 )
6E6E: dgy-06-116, a novel and selective covalent inhibitor of src kinase (10.3389/FMOLB.2020.00081 )
6F3F: autoinhibited src kinase bound to adp (10.1038/S41598-017-17703-5 )
6HVE: kinase domain of csrc in complex with compound 9 (10.1039/C9SC03445E )
6HVF: kinase domain of csrc in complex with compound 29b (10.1039/C9SC03445E )
6L8L: c-src in complex with ibrutinib (10.1016/J.BMCL.2020.127757 )
6WIW: c-src bound to atp-competitive inhibitor i14 (10.1021/ACSCHEMBIO.0C00429 )
6XVM: crystal structure of c-src sh3 domain without atcun motif: monomer 2 (10.1007/S00775-020-01785-0 )
6XVN: crystal structure of c-src sh3 domain without atcun motif: monomer 1 (10.1007/S00775-020-01785-0 )
6XVO: crystal structure of the intertwined dimer of the c-src sh3 domain without atcun motif (10.1007/S00775-020-01785-0 )
6XX2: crystal structure of the c-src sh3 domain h122r-q128k mutant in complex with cu(ii) at ph 7.5 co-crystallized with methyl beta- cyclodextrin (10.1007/S00775-020-01785-0 )
6XX3: crystal structure of the c-src sh3 domain h122r-q128e mutant in complex with cu(ii) at ph 6.5 co-crystallized with methyl beta- cyclodextrin (10.1007/S00775-020-01785-0 )
6XX4: crystal structure of the c-src sh3 domain h122r-q128e mutant in complex with ni(ii) at ph 7.5 co-crystallized with methyl beta- cyclodextrin (10.1007/S00775-020-01785-0 )
6XX5: crystal structure of the c-src sh3 domain h122r-q128k mutant in complex with ni(ii) at ph 7.5 co-crystallized with methyl beta- cyclodextrin (10.1007/S00775-020-01785-0 )
7A2O: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 4.5
7A2P: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 5.0 with peg
7A2Q: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 3.0 with peg
7A2R: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 6.0
7A2S: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 5.0
7A2T: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 4.0
7A2W: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant in complex with vsl12 at ph 3.0
7A2X: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant in complex with vsl12 at ph 5.0
7A2Y: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant in complex with vsl12 at ph 4.0
7A2Z: crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant in complex with vsl12 at ph 6.0
7A30: intertwined dimer of the c-src sh3 domain mutant q128e
7A31: crystal structure of the c-src sh3 domain mutant s94a-t98d-v111l- n113s-t114s at ph 4.5
7A32: crystal structure of the c-src sh3 domain mutant s94a-t98d-v111l- n113s-t114s at ph 7.0
7A33: crystal structure of the c-src sh3 domain mutant s94a-t98d-v111l- n113s-t114s at ph 3.0
7A34: intertwined dimer of the c-src sh3 domain mutant v111l-n113s-t114s
7A35: crystal structure of the c-src sh3 domain mutant v111l-n113s-t114s at ph 7.0
7A36: crystal structure of the c-src sh3 domain mutant v111l-n113s-t114s in 7 m urea
7A37: crystal structure of the c-src sh3 domain mutant v111l-n113s-t114s in 3 m urea
7A38: crystal structure of the c-src sh3 domain mutant v111l-n113s-t114s- q128e at ph 6.0
7A39: crystal structure of the c-src sh3 domain mutant v111l-n113s-t114s- q128e at ph 7.0
7A3A: intertwined dimer of the c-src sh3 domain mutant v111l-n113s-t114s- q128e at ph 6.0
7A3B: intertwined dimer of the c-src sh3 domain mutant e106d
7A3C: crystal structure of the c-src sh3 domain mutant l100i at ph 3.0
7A3D: intertwined dimer of the c-src sh3 domain mutant t125s
7A3E: intertwined dimer of the c-src sh3 domain mutant t126s
7AH3: kinase domain of csrc in complex with a pyrazolopyrimidine
7D57: c-src in complex with fiin-2
7D5O: c-src in complex with tas-120
7NER: crystal structure of the v-src sh3 domain q128r mutant (10.1107/S2059798321004344 )
7NES: crystal structure of the v-src sh3 domain n117d-v124l mutant (10.1107/S2059798321004344 )
7NET: crystal structure of the v-src sh3 domain w95r-i96t mutant (10.1107/S2059798321004344 )
7NG7: src kinase bound to ecf506 trapped in inactive conformation (10.1158/0008-5472.CAN-21-0613 )
7WF5: c-src in complex with ponatinib (10.1016/J.BBRC.2022.02.001 )